Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 V565 in active Crohn's disease
NL-OMON47571Phase 2Active, not recruiting
- Sponsor
- VHsquared Ltd.
- Start
- Sep 2017
- Modality
- Nanobodies (VHH) → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing V565 with Placebo (2 arms). Started Sep 2017; status: active, not recruiting.
02
Drugs
V565
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NL-OMON47571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47571.